January 2026 Snapshot

May 2026 DS

* Does Senital Node Biopsy improve survival in melanoma patients? * Co-treating Ixekizumab With Tirzepatide - does it enhance response? * Adjuvant cemiplimab in high-risk SCC, does it help? * Do we need to do CXR before starting methotrexate? * How effective are systemics at controlling generalised pustular psoriasis? * Stage IIC vs IIIA melanoma survival analysis

April 2026 Dermatology Snapshots

* Salt immersion as a treatment for warts * Targeted reapplication of treatment for scabies in infants * Changes to Advice and Guidance in NHS England * Weekly or daily bathing in patients with eczema? * Which devices to use in patient teledermoscopy? * Does AI improve FDS in real world application? * LPP guidance from EADV * Hep B guidance for patients on systemics

January 2026 Snapshot

Highlights: * A new way of thinking about diagnosing mosaic pigmentary disorders * Nail melanoma and melanonychia - length of monitoring and changes to look out for * Cutaneous immune-related adverse events and oncological outcomes * A Delphi consensus on Topical Steroid Withdrawal * European HS guidelines * Frontal Fibrosing Alopecia in men : a systematic review * Validated tools to help with suspected drug allergies and how to approach allergy labelling * Hydrocolloid dressing vs petroleum ointment application post op - how do they compare?

Threads of Consensus: Mapping Modern AGA Care

AGA Guidelines There is a large void when it comes to guidelines for the treatment of androgenetic alopecia, specifically FPHL. In this final lesson, we bring it all together, with recently published 2025 guidelines that help to fill that void and provide worldwide guidance, reflecting common practice in the UK and elsewhere.

Platelets & Potions

Platelet Rich Plasma (PRP) Some clinicians swear by it, others have had a less favourable experience with it. So, what’s the low-down on PRP for FPHL?